Clinical Effectiveness and Cost-Effectiveness of Blended Treatment for Major Depression Compared With Treatment as Usual Within Routine Care in Europe: A Noninferiority Randomized Controlled Trial
Klinische Wirksamkeit und Kosteneffektivität von Blended Treatment bei Major Depression im Vergleich zu Treatment as Usual in der Routineversorgung in Europa: nichtunterlegenheits-RCT
Interactive Journal of Medical Research · 24.09.2026 · 15 · e72866-e72866
DOI: 10.2196/72866 ↗Auf einen Blick
Bei 835 Patient:innen war bCBT bei Major Depression der TAU in den PHQ-9-Werten nicht unterlegen. Nach 12 Monaten war die Wahrscheinlichkeit für eine MDD-Episode geringer als unter TAU.
Fragestellung
Ist blended CBT bei Major Depression in der Routineversorgung klinisch nicht unterlegen und kosteneffektiv gegenüber TAU?
Methode
Multisite, randomisierte Nichtunterlegenheitsstudie in 9 europäischen Ländern; Erwachsene mit MDD und PHQ-9 ≥5; primärer Endpunkt PHQ-9; Kostenanalyse aus Gesundheitswesen-Perspektive.
Ergebnisse
bCBT war beim PHQ-9 nicht unterlegen: d =−0,26 (95 %-KI −0,43 bis −0,09) nach 3 Monaten, d =−0,21 (95 %-KI −0,39 bis −0,04) nach 6 Monaten und d =−0,01 (95 %-KI −0,19 bis 0,17) nach 12 Monaten. MDD-Episode nach 12 Monaten: OR 0,67 (95 %-KI 0,45–0,99).
Einschränkungen
Aus Sicht des Gesundheitswesens war bCBT nach 12 Monaten nicht kosteneffektiv, da die Gesamtkosten nicht signifikant niedriger waren als bei TAU.
Schlussfolgerung der Autor:innen
bCBT bietet laut Autor:innen eine wirksame und sichere digital unterstützte Alternative zu face-to-face TAU; die Kosteneffektivität hängt von der Zahlungsbereitschaft ab.
Kernaussagen
- PHQ-9: bCBT war TAU in allen Messzeitpunkten nicht unterlegen
- MDD-Episode nach 12 Monaten seltener unter bCBT
- Kosteneffektivität hing von der Zahlungsbereitschaft ab
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Interactive Journal of Medical Research, online erschienen am 24.09.2026. Verfasst von Heleen Riper und 37 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical, Neuro- and Developmental Psychology, Amsterdam Public Health Research Institute, Vrije Universiteit Amsterdam, Van der Boecho…. Die Arbeit nennt 75 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Themen: Depression
Abstract (Originalsprache)
Background
Cognitive behavioral therapy (CBT) is an effective and widely used treatment for major depressive disorder (MDD). However, access is limited by long waiting lists and a shortage of trained therapists. Evidence-based guided and self-guided digital interventions can address these challenges, but their large-scale adoption in routine primary and specialized mental health care has been slow. Blended CBT (bCBT), combining face-to-face therapy with structured, guided digital treatment modules, may increase treatment capacity while maintaining the benefits of therapist support.
Objective
The European Comparative Effectiveness Research on Internet-based Depression Treatment study, conducted across 9 European countries, is the first large-scale comparative bCBT study for MDD. The hypothesis was that bCBT is clinically noninferior and cost-effective when compared with treatment as usual (TAU), which mainly consisted of face-to-face CBT.
Methods
A multisite randomized controlled trial was conducted with a noninferiority margin of d =0.20. Main inclusion criteria were age ≥18 years, a diagnosis of MDD based on the Mini International Neuropsychiatric Interview, and a baseline Patient Health Questionnaire-9 (PHQ-9) score of ≥5. The primary outcome was the PHQ-9, with secondary outcomes including MDD remission at 12 months, therapeutic alliance, and costs. Intention-to-treat analyses were performed, and linear mixed modeling was used to assess intervention effects. Cost-effectiveness analyses were conducted from a health care perspective.
Results
A total of 835 patients were included in the study. bCBT was shown to be noninferior to TAU on the primary PHQ-9 outcome during treatment (3 months after the baseline assessment, d =−0.26, 95% CI −0.43 to −0.09), at 6 months (posttreatment, d =−0.21, 95% CI −0.39 to−0.04), and at 12-month follow-up ( d =−0.01, 95% CI −0.19 to 0.17). Furthermore, the bCBT group had a significantly lower likelihood of experiencing an MDD episode at 12 months (odds ratio 0.67, 95% CI 0.45‐0.99). Subgroup analyses indicated that participants with and with no antidepressant use at baseline in both groups benefited equally from their treatment. Deterioration rates (Reliable Change Index) were below 5% in both groups. bCBT appeared acceptable for patients and therapists, with a strong working alliance in both groups. From a health care perspective, bCBT was not cost-effective at 12 months' assessment, as its total costs were not significantly lower than TAU. However, the probability that bCBT is cost-effective is high (0.95) at a willingness to pay (WTP) of €3800 per improvement in the PHQ-9 score, and 0.76 at a WTP of €10,000 per MDD case prevented (average 2017 exchange rate was €1=US $1.13). Conclusions bCBT offers an effective and safe digitally supported alternative to face-to-face TAU for patients with MDD and their therapists in routine clinical care. From a health care perspective, its cost-effectiveness depends on policymakers’ WTP for the additional clinical benefits achieved.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Clinical, Neuro- and Developmental Psychology, Amsterdam Public Health Research Institute, Vrije Universiteit Amsterdam, Van der Boechorststraat 7, Amsterdam, 1081 BT, The Netherlands.
- Amsterdam UMC, Location Vrije Universiteit Amsterdam, Department of Psychiatry, Amsterdam Public Health Research Institute, Amsterdam, The Netherlands.
- Department of Health Sciences, Faculty of Earth and Life Sciences, Amsterdam Public Health Research Institute, Vrije Universiteit, Amsterdam, The Netherlands.
- Department of Psychology, Education and Child Studies, Clinical Psychology, Erasmus School of Social and Behavioral Sciences, Erasmus University Rotterdam, Rotterdam, The Netherlands.
- Department of Psychology and Behavioral Sciences, Aarhus University, Aarhus, Denmark.
- ECEVE, UMR 1123, Inserm, Université Paris Cité, Paris, France.
Zitieren
APA
Riper, H., Kleiboer, A., Hoogendoorn, A., Bosmans, J., Schulte, M., Mathiasen, K., Hazo, J. B., Holtzmann, J., Chevreul, K., Ebert, D. D., Titzler, I., Berking, M., Funk, B., van Schaik, A., Kemmeren, L., Cieslak, R., Smoktunowicz, E., Maj, A., Botella, C., …, & Cuijpers, P. (2026). Clinical Effectiveness and Cost-Effectiveness of Blended Treatment for Major Depression Compared With Treatment as Usual Within Routine Care in Europe: A Noninferiority Randomized Controlled Trial. Interactive Journal of Medical Research, 15, e72866-e72866. https://doi.org/10.2196/72866
Vancouver
Riper H, Kleiboer A, Hoogendoorn A, Bosmans J, Schulte M, Mathiasen K, et al. Clinical Effectiveness and Cost-Effectiveness of Blended Treatment for Major Depression Compared With Treatment as Usual Within Routine Care in Europe: A Noninferiority Randomized Controlled Trial. Interactive Journal of Medical Research. 2026;15:e72866-e72866. doi:10.2196/72866
BibTeX
@article{Riper2026,
author = {Riper, Heleen and Kleiboer, Annet and Hoogendoorn, Adriaan and Bosmans, Judith and Schulte, Mieke and Mathiasen, Kim and Hazo, Jean Baptiste and Holtzmann, Jerome and Chevreul, Karine and Ebert, David Daniel and Titzler, Ingrid and Berking, Mathias and Funk, Burkhardt and van Schaik, Anneke and Kemmeren, Lise and Cieslak, Roman and Smoktunowicz, Ewelina and Maj, Anna and Botella, Cristina and Garcia-Palacios, Azucena and Banos, Rosa and Herrero, Rocío and Andersson, Gerhard and Topooco, Naira and Vernmark, Kristofer and Berger, Thomas and Krieger, Tobias and Cerga-Pashoja, Arlinda and Doukani, Asmae and Araya, Ricardo and Karyotaki, Eirini and Kolovos, Spyros and Hoogendoorn, Mark and van Breda, Ward and van de Ven, Pepijn and Rocha, Artur and Gonçalves, Gonçalo and Cuijpers, Pim},
title = {Clinical Effectiveness and Cost-Effectiveness of Blended Treatment for Major Depression Compared With Treatment as Usual Within Routine Care in Europe: A Noninferiority Randomized Controlled Trial},
journal = {Interactive Journal of Medical Research},
year = {2026},
volume = {15},
pages = {e72866--e72866},
doi = {10.2196/72866}
}
EUVIMED